Cancrum oris
Noma
Revisado por Dr Philippa Vincent, MRCGPÚltima atualização por Dr Colin Tidy, MRCGPÚltima atualização 17 de maio de 2023
Atende aos diretrizes editoriais
- BaixarBaixar
- Compartilhar
- Language
- Discussão
- Ask Patient
- Versão em Áudio
- Adicionar às fontes preferidas no Google
Profissionais de Saúde
Os artigos de Referência Profissional são projetados para uso por profissionais de saúde. Eles são escritos por médicos do Reino Unido e baseados em evidências de pesquisa, diretrizes do Reino Unido e da Europa. Você pode encontrar um dos nossos artigos de saúde mais útil.
Synonyms: noma (from Greek: to devour); gangrenous stomatitis; face of poverty (flourishes where poverty is rife)
Contexto1
Cancrum oris (noma) is a mutilating necrotising disease. The consequent fasciíte necrosante, myonecrosis, and osteonecrosis results in destruction of facial structures with severe functional impairment and disfigurement.
Noma is not recurrent and is not transmissible.
Other oral problems are outlined in the related separate article Problemas na Boca.
Epidemiologia1 2
A disease of children (especially aged 2-6 years), it is seen in developing countries, especially in sub-Saharan Africa, with rare cases reported in Asia and South America. The World Health Organization (WHO) estimates that 140,000 people are affected per year.
Some cultures do not treat the disease, as it is considered taboo. This results in a barrier to detection of the disorder and to its appropriate management.
Etiologia3
The exact aetiology is unknown but it is caused primarily by a polybacterial infection with secondary ischaemia, particularly in children who are malnourished or debilitated by systemic conditions including - but not limited to - malaria, measles, tuberculosis, and HIV/AIDS.1
Fatores de risco
Poverty.
Pobre higiene oral.
Pobre saneamento.
Living in close proximity to domestic animals.
Sarampo - common in tropical Africa following an ulcerative gingivitis.
Bacillary dysentery.
Leukaemia - a terminal manifestation.
Apresentação1
The course of the disease is very rapid with progression from necrotising stomatitis to full thickness destruction taking just a few days.
Prior to necrosis:
Poor oral hygiene is nearly always present.
Excessive salivation.
Malodour from the mouth.
Grey discoloration.
Gingival ulcer formation.
Followed by rapid, painless and extensive necrosis of the oral cavity, which can involve the cheek, nose, palate and bones.
In 'noma pudendi' there is necrosis of the genitalia and, in 'noma neonatorum', mucocutaneous gangrene occurs during the neonatal period.4
Investigações
Swabs and culture for organisms - Borrelia vincentii and fusiform bacilli are commonly found, as are anaerobes in rapidly progressing cases.5
Facial X-rays and CT scan to determine the extent of involvement.
Gestão1 6
Debilitated patients with established necrotising stomatitis should immediately be admitted to hospital for intravenous broad-spectrum antibiotics, fluid and electrolytes, nutritional supplementation, and supportive medical care. Superficial necrotic tissue and mobile teeth should be removed, followed by frequent irrigation.
Later treatment requires plastic surgery with facial reconstruction and possible repair of temporomandibular joint.7
Complicações1
Desidratação.
Sepse.
Airway compromise.
Facial disfigurement.
Psychological stress.
Prognóstico
Noma has a mortality rate of 90% within weeks after the onset of noma if left untreated.6
Atualizações exclusivas para profissionais de saúde
Mantenha-se informado com as últimas atualizações clínicas, insights profissionais e orientações baseadas em evidências. O boletim informativo Patient Pro seleciona conteúdo essencial para profissionais de saúde—entregue diretamente na sua caixa de entrada.
Ao se inscrever, você aceita nossos Política de Privacidade. Você pode cancelar a inscrição a qualquer momento. Nunca vendemos seus dados.
Leitura adicional e referências
- Khammissa RAG, Lemmer J, Feller L; Noma staging: a review. Trop Med Health. 2022 Jun 13;50(1):40. doi: 10.1186/s41182-022-00431-6.
- Feller L, Khammissa RAG, Altini M, et al; Noma (cancrum oris): An unresolved global challenge. Periodontol 2000. 2019 Jun;80(1):189-199. doi: 10.1111/prd.12275.
- Noma; World Health Organization (WHO), 2016
- Gezimu W, Demeke A, Duguma A; Noma - a neglected disease of malnutrition and poor oral hygiene: A mini-review. SAGE Open Med. 2022 May 13;10:20503121221098110. doi: 10.1177/20503121221098110. eCollection 2022.
- Parikh TB, Nanavati RN, Udani RH; Noma neonatorum. Indian J Pediatr. 2006 May;73(5):439-40.
- Paster BJ, Falkler Jr WA Jr, Enwonwu CO, et al; Prevalent bacterial species and novel phylotypes in advanced noma lesions. J Clin Microbiol. 2002 Jun;40(6):2187-91.
- Farley E, Mehta U, Srour ML, et al; Noma (cancrum oris): A scoping literature review of a neglected disease (1843 to 2021). PLoS Negl Trop Dis. 2021 Dec 14;15(12):e0009844. doi: 10.1371/journal.pntd.0009844. eCollection 2021 Dec.
- Enwonwu CO; Noma--the ulcer of extreme poverty. N Engl J Med. 2006 Jan 19;354(3):221-4.
Sobre o revisorVer biografia completa

Dr Philippa Vincent, MRCGP
Médico Generalista, Autor Médico
MB BS, Bsc, MRCGP (2000), DCH, DFSRH, DRCOG
Dra Philippa Vincent é um médico do NHS trabalhando no norte de Londres.


